GCM
CNMD icon

Graham Capital Management’s CONMED CNMD Stock Holding History

Graham Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,823
Closed -$321K – 1274
2025
Q3 		$321K Buy
6,823
+368
+6% +$19.1K 0.01% 830
2025
Q2 		$336K Sell
6,455
-2,992
-32% -$164K 0.01% 957
2025
Q1 		$571K Buy
9,447
+2,233
+31% +$144K 0.01% 755
2024
Q4 		$494K Buy
7,214
+518
+8% +$36.1K 0.01% 742
2024
Q3 		$482K Sell
6,696
-6,374
-49% -$450K 0.01% 646
2024
Q2 		$906K Buy
13,070
+9,760
+295% +$712K 0.02% 440
2024
Q1 		$265K Buy
+3,310
New +$295K 0.01% 829
2023
Q4 		– Sell
-2,058
Closed -$208K – 1045
2023
Q3 		$208K Buy
+2,058
New +$236K ﹤0.01% 849

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Graham Capital Management's CNMD Position: Q4 2025 in Review

Graham Capital Management sold out of CONMED (CNMD) in Q4 2025, closing a stake of 6,823 shares — an estimated $321K sold.

Graham Capital Management first reported a position in CNMD in Q3 2023 and held it in 8 quarters. The position peaked at $906K in Q2 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Graham Capital Management reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 6,823 CONMED shares in Q4 2025, an estimated $321K.
  • Graham Capital Management first reported a position in CONMED in Q3 2023 and held it in 8 quarters.
  • Graham Capital Management's CONMED position peaked at $906K in Q2 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.